Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Current Leases for 6 consecutive years, with $268000.0 as the latest value for Q4 2024.

  • Quarterly Current Leases fell 38.25% to $268000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $268000.0 through Dec 2024, down 38.25% year-over-year, with the annual reading at $268000.0 for FY2024, 38.25% down from the prior year.
  • Current Leases for Q4 2024 was $268000.0 at Whitehawk Therapeutics, down from $322000.0 in the prior quarter.
  • The five-year high for Current Leases was $434000.0 in Q4 2023, with the low at $9955.0 in Q2 2021.
  • Average Current Leases over 5 years is $257931.6, with a median of $322000.0 recorded in 2024.
  • The sharpest move saw Current Leases plummeted 91.04% in 2021, then skyrocketed 3154.65% in 2022.
  • Over 5 years, Current Leases stood at $94787.0 in 2020, then skyrocketed by 38.2% to $131000.0 in 2021, then skyrocketed by 200.76% to $394000.0 in 2022, then grew by 10.15% to $434000.0 in 2023, then tumbled by 38.25% to $268000.0 in 2024.
  • According to Business Quant data, Current Leases over the past three periods came in at $268000.0, $322000.0, and $374000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.